Lars Bo Jørgensen (@larsbojrgensen2) 's Twitter Profile
Lars Bo Jørgensen

@larsbojrgensen2

PhD student / #Multimorbidity #Exercisefirst

ID: 914393305949011968

calendar_today01-10-2017 07:35:27

49 Tweet

101 Followers

163 Following

Lars Bo Jørgensen (@larsbojrgensen2) 's Twitter Profile Photo

So what’s up? Well, of 11.500 papers, about 320 made it to the full text screening. Looking forward to data extraction after a couple of weeks of doing nothing but enjoying the remaining danish summer. Stay tuned! PROgrez Søren T. Skou Lars Hermann Tang

Pætur Mikal Holm (@pm_holm) 's Twitter Profile Photo

Check out our newly published scoping review on clinicians' attitudes and beliefs to physical activity and exercise therapy as treatment in knee and hip OA (thread below): sciencedirect.com/science/articl… PROgrez FOF research unit NSRsygehuse Idræt og Biomekanik #ExerciseFirst

Lars Bo Jørgensen (@larsbojrgensen2) 's Twitter Profile Photo

Does transition from hospital to municipality affect drop out rates in exercise based cardiac rehabilitation? 👇🏻👇🏻👇🏻👇🏻👇🏻Dropout during a 12-week transitional exercise-based cardiac rehabilitation programme: a mixed-methods prospective cohort study academic.oup.com/eurjcn/advance…

Lars Bo Jørgensen (@larsbojrgensen2) 's Twitter Profile Photo

How about those apps? Can they help treat chronic disease? Listen to my skilled collegue Graziella Zangger share her insights! (Disclaimer - it’s in danish!) open.spotify.com/episode/4UKILL…

Lars Bo Jørgensen (@larsbojrgensen2) 's Twitter Profile Photo

Milestone! Submission of the first paper being first author is a huge deal when being a humble PhD student. Even if the paper does not make it to peer review in this specific Journal, it is still a big deal.

Milestone! Submission of the first paper being first author is a huge deal when being a humble PhD student. Even if the paper does not make it to peer review in this specific Journal, it is still a big deal.
Heino Knudsen (@heinoknudsen) 's Twitter Profile Photo

Vi skal forebygge mere, så borgerne kan få flere gode leveår. Spændene initiativer i gang hos PROgrez og Søren T. Skou, som bl.a. vil behandle og forebygge kronisk sygdom med fysisk aktivitet. Allerede gode resultater! En lille træning blev det også til😅 NSRsygehuse #sundpol

Lars Bo Jørgensen (@larsbojrgensen2) 's Twitter Profile Photo

Interesseret i udvikling af online træningsredskaber til personer med diabetes? Så hold øje med min kollega Sofies PhD projekt! 👇🏻

Lars Bo Jørgensen (@larsbojrgensen2) 's Twitter Profile Photo

Milestone, our paper is finally published! Read and share if you are interested in physical activity and multimorbidity! journals.plos.org/plosone/articl…

Lars Bo Jørgensen (@larsbojrgensen2) 's Twitter Profile Photo

One of the perks of being a PhD student is the wide network of collaboraters that you get! I am now halfway through a internship at the Danish Cancer Society where I get to network, be inspired, assisted at also exchange ideas and input to other research projects than my own. 🙏🏻

Edinburgh Primary Care and Multimorbidity (@multimorbidity1) 's Twitter Profile Photo

New paper. The effects of treatment on quality of life in clinical trials did not vary by multimorbidity (reassuring) although have to remember that most people with multimorbidity (especially complex) or polypharmacy are excluded from trials journals.plos.org/plosmedicine/a…

Søren T. Skou (@stskou) 's Twitter Profile Photo

Tillykke Lars Bo Jørgensen 👏 PhD forsvar på SUH i Køge den 8.marts klokken 13 om fysisk aktivitet blandt mennesker med multisygdom. Lars er en glimrende formidler og god til at knytte forskning tæt på praksis, så en rigtig god dag for klinikere til at få et indblik i emnet.

Tillykke <a href="/LarsBoJrgensen2/">Lars Bo Jørgensen</a> 👏
PhD forsvar på SUH i Køge den 8.marts klokken 13 om fysisk aktivitet blandt mennesker med multisygdom. Lars er en glimrende formidler og god til at knytte forskning tæt på praksis, så en rigtig god dag for klinikere til at få et indblik i emnet.